- Skin Cancer Rare -- But More Deadly -- In People With Darker Skin
New research from the University of Cincinnati (UC) shows that dark-skinned people--commonly thought to be "immune" to most skin cancers--are more likely than whites to die from skin cancer and its related complications. - New Affordable SOLAR Shield Sun Protective Clothing Tackles Skin Cancer Epidemic
New, exclusive SOLAR Shield apparel is now available at SOLARShieldDirect.com. This expanding line of affordable, quality sun protective apparel offers the average consumer a selection of men's, women's and youth styles without the high price tag found at most sun protective clothing retailers. - Nexavar Receives FDA Fast Track Designation For Skin Cancer
Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced today that Nexavar(R) (sorafenib) tablets has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of advanced (including locally unresectable and metastatic) melanoma, a form of skin cancer. Nexavar was approved by the FDA in December 2005 for the treatment of patients with advanced renal cell carcinoma (RCC).
|